Phase 1 study of combinatorial sorafenib, G-CSF, and plerixafor treatment in relapsed/refractory, FLT3-ITD-mutated acute myelogenous leukemia patients

Gautam Borthakur, Zhihong Zeng, Jorge E. Cortes, Hsiang Chun Chen, Xuelin Huang, Marina Konopleva, Farhad Ravandi, Tapan Kadia, Keyur P. Patel, Naval Daver, Mary A. Kelly, Teresa McQueen, Ru Yiu Wang, Hagop Kantarjian, Michael Andreeff

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 1 study of combinatorial sorafenib, G-CSF, and plerixafor treatment in relapsed/refractory, FLT3-ITD-mutated acute myelogenous leukemia patients'. Together they form a unique fingerprint.

Medicine & Life Sciences